LEADER 01527nas  2200457-a 450 
001 9910985992403321
005 20241221110558.0
011   $a1744-8344
035   $a(CKB)111058298582006
035   $a(CONSER)--2004243171
035   $a(MiFhGG)3GLS
035   $a(EXLCZ)99111058298582006
100   $a20030617a20039999  ---         -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aExpert review of cardiovascular therapy
210   $aLondon, UK $cFuture Drugs Ltd
210 21$aLondon :$cInforma Healthcare
210 31$aAbingdon, Oxford :$cTaylor & Francis
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$aPrint version: Expert review of cardiovascular therapy. 1477-9072 (DLC)  2004243171 (OCoLC)54687403 
517 3 $aCardiovascular therapy
531   $aEXPERT REV CARDIOVASC THER
531 10$aExpert Rev Cardiovasc Ther
606   $aCardiovascular agents$xResearch$vPeriodicals
606   $aCardiovascular Diseases$xtherapy
606   $aCardiovascular agents$xResearch$2fast$3(OCoLC)fst00847152
608   $aPeriodical.
608   $aReview.
608   $aPeriodicals.$2fast
615  0$aCardiovascular agents$xResearch
615 12$aCardiovascular Diseases$xtherapy.
615  7$aCardiovascular agents$xResearch.
906   $aJOURNAL
912   $a9910985992403321
920   $aexl_impl conversion
996   $aExpert review of cardiovascular therapy$92324055
997   $aUNINA